Wayne Gordon
General Counsel bei A-Bio Pharma Pte Ltd.
Aktive Positionen von Wayne Gordon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
A-Bio Pharma Pte Ltd.
 A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | General Counsel | 01.01.2008 | - |
Karriereverlauf von Wayne Gordon
Ehemalige bekannte Positionen von Wayne Gordon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Corporate Officer/Principal | - | - |
Ausbildung von Wayne Gordon
| University of Illinois | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Singapur | 2 |
Operativ
| General Counsel | 1 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Commercial Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
A-Bio Pharma Pte Ltd.
A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | Commercial Services |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
- Börse
- Insiders
- Wayne Gordon
- Erfahrung
